Skip to main content
CBIO filings

Corporate insider profile

Richard William Scalzo Filing Activity

Latest reported as Chief Financial Officer of CRESCENT BIOPHARMA, INC. (CBIO).

Purchase filings
0
Reported companies
1
Net open-market value
-$20,004.88
Latest transaction
Jun 22, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 22, 2026CRESCENT BIOPHARMA, INC. (CBIO)Chief Financial OfficerSale1,112$17.99$20,005